Lisa Feng, DrPH, is the Senior Directory of Health Policy at Alexion Pharmaceuticals, a global biopharmaceutical company dedicated to improving the lives of patients with rare and devastating diseases. In her role at Alexion, Dr. Feng helps the company assess the evolving health policy landscape to help ensure patient access to current and future innovations. Prior to Alexion, Dr. Feng was Senior Director of Policy and Advocacy at the Cystic Fibrosis Foundation, where she led state and federal policy analysis and advocacy related to access to cystic fibrosis care and treatments. Dr. Feng was also responsible for the Value and Coverage program at FasterCures, a center of the Milken Institute. She has worked extensively on programs funded by the Center for Medicare and Medicaid Innovation and the Robert Wood Johnson Foundation. Dr. Feng is a health services researcher and has published on topics such as primary care quality, electronic health records, and emergency department care. She received her doctorate in health policy at the George Washington University Milken Institute School of Public Health.